• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    Omega Alpha SPAC filed SEC Form 8-K: Other Events

    12/23/22 4:05:26 PM ET
    $OMEG
    Business Services
    Finance
    Get the next $OMEG alert in real time by email
    0001832010 false 0001832010 2022-12-23 2022-12-23 iso4217:USD xbrli:shares iso4217:USD xbrli:shares

     

     

     

    UNITED STATES

    SECURITIES AND EXCHANGE COMMISSION

    Washington, D.C. 20549

     

    FORM 8-K

     

    CURRENT REPORT

     

    PURSUANT TO SECTION 13 OR 15(d) OF THE

    SECURITIES EXCHANGE ACT OF 1934

     

    Date of Report (Date of earliest event reported): December 23, 2022

     

    OMEGA ALPHA SPAC

    (Exact name of registrant as specified in its charter)

     

    Cayman Islands   001-039840   98-1566615
    (State or other jurisdiction
    of incorporation)
      (Commission
    File Number)
      (IRS Employer
    Identification No.)

     

    888 Boylston Street, Suite 1111
    Boston, MA
      02199
    (Address of principal executive offices)   (Zip Code)

     

    Registrant’s telephone number, including area code: (857) 268-4429

     

    Not Applicable
    (Former name or former address, if changed since last report)

     

    Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

     

    ¨ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

     

    ¨ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

     

    ¨ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

     

    ¨ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

     

    Securities registered pursuant to Section 12(b) of the Act:

     

    Title of each class Trading
    Symbol(s)
    Name of each exchange on
    which registered
    Class A ordinary shares, $0.0001 par value per share OMEG The NASDAQ Capital Market LLC

     

    Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).

     

    Emerging growth company  x

     

    If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.  ¨

     

     

     

    Item 8.01. Other Events.

     

    The Board of Directors (the “Board”) of Omega Alpha SPAC (the “Company”) has determined that the Company will not be able to consummate an initial business combination within the time period required by its Amended and Restated Memorandum and Articles of Association (the “Articles”). Accordingly, the Board has determined that it is in the best interest of the Company and its shareholders to liquidate early and the Company will redeem all of its outstanding Class A ordinary shares, par value $0.0001, effective as of the close of business on December 28, 2022.

     

    As such, in accordance with the Company’s Articles, the Company will:

     

    ·cease all operations as of December 28, 2022, except those required to wind up the Company’s business;

     

    ·as promptly as reasonably possible, redeem the Public Shares, at a per-share price, payable in cash, equal to the aggregate amount then on deposit in the Company’s trust account (the “Trust Account”), including interest earned on the funds held in the Trust Account and not previously released to the Company to pay the Company’s income taxes, if any (less $100,000 of interest to pay dissolution expenses), divided by the number of the then-outstanding Public Shares, which redemption will completely extinguish public shareholders’ rights as shareholders of the Company (including the right to receive further liquidation distributions, if any); and

     

    ·as promptly as reasonably possible following such redemption, subject to the approval of the Company’s remaining shareholders and the Company’s board of directors, liquidate and dissolve, subject to the Company’s obligations under Cayman Islands law to provide for claims of creditors and the requirements of other applicable law.

     

    The per-share redemption price for the public shares will be approximately $10.11 (the “Redemption Amount”). The balance of the Trust Account as of December 22, 2022 was approximately $139,634,302.58, which includes approximately $1,634,302.58 in interest and dividend income (excess of cash over $ 138,000,000, the funds deposited into the Trust Account). In accordance with the terms of the related trust agreement, the Company expects to retain $100,000 of the interest and dividend income from the Trust Account to pay dissolution expenses.

     

    As of the close of business on December 28, 2022, the Public Shares will be deemed cancelled and will represent only the right to receive the Redemption Amount.

     

    The Redemption Amount will be payable to the holders of the Public Shares upon presentation of their respective stock or unit certificates or other delivery of their shares or units to the Company’s transfer agent, Continental Stock Transfer & Trust Company. Beneficial owners of public shares held in “street name,” however, will not need to take any action in order to receive the Redemption Amount.

     

    The Company’s sponsor has waived its redemption rights with respect to the outstanding Class A ordinary shares, held by the sponsor, and the Class B ordinary shares. After December 28, 2022, the Company shall cease all operations except for those required to wind up the Company’s business.

     

    The Company expects that Nasdaq will file a Form 25 with the U.S. Securities and Exchange Commission (the “Commission”) to delist its securities. The Company thereafter expects to file a Form 15 with the Commission to terminate the registration of its securities under the Securities Exchange Act of 1934, as amended.

     

     

    Forward-Looking Statements

     

    This Current Report on Form 8-K includes “forward-looking statements” within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. When used in this Current Report on Form 8-K, the words “could,” “should,” “will,” “may,” “believe,” “anticipate,” “intend,” “estimate,” “expect,” “project,” the negative of such terms and other similar expressions are intended to identify forward-looking statements, although not all forward-looking statements contain such identifying words. Such forward-looking statements are based on current information and expectations, forecasts and assumptions, and involve a number of judgments, risks and uncertainties. Accordingly, forward-looking statements should not be relied upon as representing the Company’s views as of any subsequent date, and the Company does not undertake any obligation to update forward-looking statements to reflect events or circumstances after the date they were made, whether as a result of new information, future events or otherwise, except as may be required under applicable securities laws. You should not place undue reliance on these forward-looking statements. As a result of a number of known and unknown risks and uncertainties, actual results or performance may be materially different from those expressed or implied by these forward-looking statements. Forward-looking statements are subject to numerous conditions, many of which are beyond the control of the Company, including those set forth in the “Risk Factors” in the Company’s registration statement on Form S-1 (Registration No. 333-251551), as amended, initially filed with the Commission on December 21, 2020, relating to its initial public offering, annual, quarterly reports and subsequent reports filed with the Commission, as amended from time to time. Copies of such filings are available on the Commission’s website, www.sec.gov. The Company undertakes no obligation to update these statements for revisions or changes after the date of this Current Report on Form 8-K, except as required by law.

     

     

    SIGNATURE

     

    Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

     

    Dated: December 23, 2022

     

      OMEGA ALPHA SPAC
       
       
      By: /s/ Otello Stampacchia
      Name: Otello Stampacchia
      Title: Chief Executive Officer

     

     

    Get the next $OMEG alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $OMEG

    DatePrice TargetRatingAnalyst
    More analyst ratings

    $OMEG
    SEC Filings

    View All

    SEC Form 15-12G filed by Omega Alpha SPAC

    15-12G - Omega Alpha SPAC (0001832010) (Filer)

    1/6/23 6:11:33 AM ET
    $OMEG
    Business Services
    Finance

    SEC Form 25-NSE filed by Omega Alpha SPAC

    25-NSE - Omega Alpha SPAC (0001832010) (Subject)

    12/27/22 4:15:27 PM ET
    $OMEG
    Business Services
    Finance

    Omega Alpha SPAC filed SEC Form 8-K: Other Events

    8-K - Omega Alpha SPAC (0001832010) (Filer)

    12/23/22 4:05:26 PM ET
    $OMEG
    Business Services
    Finance

    $OMEG
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    Omega Funds Closes Oversubscribed $650 Million Fund VII to Invest in Transformative Life Science Companies

    BOSTON, Dec. 17, 2021 /PRNewswire/ -- Omega Funds, a leading international healthcare venture capital firm focused on delivering impactful medicines to patients, today announced it has closed its seventh and largest fund with $650 million in limited partner capital commitments. The new fund, Omega Fund VII, L.P. ("Fund VII"), was oversubscribed, exceeding the firm's targeted raise of $500 million, and included strong support from both new and existing limited partners. With Fund VII, the firm will continue to execute on its strategy of creating and investing in life sciences companies in the US and Europe that target severe, unmet medical needs. Since its inception in 2004, Omega Funds has r

    12/17/21 8:00:00 AM ET
    $ADGI
    $ICVX
    $IKNA
    Biotechnology: Pharmaceutical Preparations
    Health Care
    Biotechnology: Biological Products (No Diagnostic Substances)
    Business Services

    $OMEG
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    SEC Form SC 13G/A filed by Omega Alpha SPAC (Amendment)

    SC 13G/A - Omega Alpha SPAC (0001832010) (Subject)

    2/14/23 2:16:43 PM ET
    $OMEG
    Business Services
    Finance

    SEC Form SC 13G/A filed by Omega Alpha SPAC (Amendment)

    SC 13G/A - Omega Alpha SPAC (0001832010) (Subject)

    2/14/23 7:41:31 AM ET
    $OMEG
    Business Services
    Finance

    SEC Form SC 13G/A filed by Omega Alpha SPAC (Amendment)

    SC 13G/A - Omega Alpha SPAC (0001832010) (Subject)

    2/9/23 11:07:54 AM ET
    $OMEG
    Business Services
    Finance